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Abstract
The intracellular motor protein myosin Va is involved in nitrergic neurotransmission possibly by trafficking of neuronal nitric
oxide synthase (nNOS) within the nerve terminals. In this study, we examined the role of myosin Va in the stomach and
penis, proto-typical smooth muscle organs in which nitric oxide (NO) mediated relaxation is critical for function. We used
confocal microscopy and co-immunoprecipitation of tissue from the gastric fundus (GF) and penile corpus cavernosum
(CCP) to localize myosin Va with nNOS and demonstrate their molecular interaction. We utilized in vitro mechanical studies
to test whether smooth muscle relaxations during nitrergic neuromuscular neurotransmission is altered in DBA (dilute,
brown, non-agouti) mice which lack functional myosin Va. Myosin Va was localized in nNOS-positive nerve terminals and
was co-immunoprecipitated with nNOS in both GF and CCP. In comparison to C57BL/6J wild type (WT) mice, electrical field
stimulation (EFS) of precontracted smooth muscles of GF and CCP from DBA animals showed significant impairment of
nitrergic relaxation. An NO donor, Sodium nitroprusside (SNP), caused comparable levels of relaxation in smooth muscles of
WT and DBA mice. These normal postjunctional responses to SNP in DBA tissues suggest that impairment of smooth muscle
relaxation resulted from inhibition of NO synthesis in prejunctional nerve terminals. Our results suggest that normal
physiological processes of relaxation of gastric and cavernosal smooth muscles that facilitate food accommodation and
penile erection, respectively, may be disrupted under conditions of myosin Va deficiency, resulting in complications like
gastroparesis and erectile dysfunction.
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Introduction
Nitric oxide (NO) produced by splice variants of the enzyme
neuronal nitric oxide synthase (nNOS) has been shown to be a
major inhibitory neurotransmitter at smooth muscle neuromus-
cular junctions. Smooth muscle relaxation facilitated by NO
released from nerve varicosities subserves essential physiological
functions in many organ systems that are as diverse as gastric
motility and penile erection [1–4]. In these prototypical examples
of nitrergic neurotransmission, impaired relaxation has been
shown to cause, respectively, a variety of gastrointestinal motility
disorders including loss of gastric accommodation [5] and erectile
dysfunction [6].
During nitrergic neurotransmission, NO is synthesized de novo
and released on demand from nitrergic varicosities [7]. Failed
nitrergic neurotransmission may result from an absence or critical
reduction in the amount of nNOS or impairment of its catalytic
function. Many factors determine the catalytic activity of nNOS
including dimerization [8–9], and its interaction with regulatory
proteins and calcium ions [10–12]. Moreover, the subcellular
localization of nNOS also regulates its catalytic activity [13–15].
Within enteric varicosities, membrane localization of nNOSa has
been shown to be necessary for optimal NO synthesis [15].
nNOSa has an N-terminal PDZ domain which binds the PDZ
domains of PSD95, a membrane bound scaffolding protein
concentrated at ‘active zones’ [8,15]. These zones are character-
ized by a supra-molecular assembly of nNOSa dimers, close to the
source of calcium surge during an action potential, thus optimizing
NO synthesis and ensuring focal release of NO [14–15].
While nNOS tethering to the membrane has been well studied,
the mechanisms involved in the translocation of nNOSa from the
cytosol to the varicosity membrane have not been fully clarified. It
was reported that PIN (protein inhibitor of nNOS), also identified
as LC8 (light chain 8 kDa), may be involved in the transport of
cytosolic nNOSa to varicosity membranes [16], and regulation of
nNOSa activity [16–17]. LC8 has been demonstrated not only in
enteric nerve varicosities [16], but also in penile cavernosal nerves
[17], central nervous system (CNS) nerve terminals [18] and other
cellular sites where nNOS transcytosis has been reported [19]. In
the gut, LC8 acts as an adaptor protein that binds nNOSa to
myosin Va [20], an unconventional non-muscle cytoskeletal motor
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protein known to transport a variety of intracellular cargo along
actin filaments. A recent study in mice with mutation in the
myosin Va gene showed that membrane associated nNOSa is
reduced in isolated enteric nerve varicosities and that in vitro NO
production as well as nitrergic inhibitory junction potentials in the
stomach are significantly diminished [20]. These results provided
evidence that myosin Va may be involved in intravaricosity
translocation of nNOSa to the membrane and hence nitrergic
neurotransmission. However, it is not known whether mechanical
relaxation of the gastric smooth muscles, which precedes gastric
accommodation, is impaired in myosin Va deficient mice.
Analogous to its role in the stomach, nitrergic neurotransmis-
sion provokes smooth muscle relaxation in the corpus cavernosum
of the penis (CCP). Relaxation of cavernosal smooth muscle
permits filling of the CCP with blood leading to penile erection [3–
6]. The nNOS splice variant expressed in penile nitrergic nerves
(PnNOS) bears molecular homology to nNOSm in striated muscles
[21] and differs structurally from the nNOS splice variant
expressed in the stomach (nNOSa). Despite these isoform
differences, the biology of nNOS appears comparable in the penis
and stomach, including interaction of the enzyme with LC8 and its
localization to varicosity membranes [17,20]. However, the role of
myosin Va in PnNOS mediated nitrergic relaxation in the penis
has not been investigated previously.
The purpose of the present study was to determine the
functional role of myosin Va in nitrergic neurotransmission in
representative, yet distinct smooth muscle systems. Therefore,
nitrergic nerve mediated smooth muscle relaxation was compared
in GF and CCP of normal and myosin Va-deficient mice.
Materials and Methods
The study protocol was conducted according to the recom-
mendations in the Guide for the Care and Use of Laboratory
Animals of the NIH and approved by the Institutional Animal
Care and Use Committee of VA Boston Healthcare System
(#101W).
DBA Mice
Male DBA mice (DBA/2J strain, Jackson Labs, 27.561.8 weeks
old) were used as models of myosin Va deficiency. DBA mice lack
cellular myosin Va due to an inherited frameshift mutation in the
MYO5A gene, induced by a proviral/inactivating insertion [22].
This mouse strain derives its name from its coat-color alleles called
dilute (d), brown (b), and non-agouti (a). The lightening of the
color coat is caused by defective transport of melanin containing
melanosomes in melanocytes due to deficiency of myosin Va [23].
Male C57BL/6J wild type (WT) mice with black coat color served
as controls (22.962.2 weeks old).
Confocal Microscopy
Tissue samples from the GF of the stomach and the corpora
cavernosa of the penis (CCP) were harvested from WT mice
immediately after euthanasia, embedded in cryoprotective com-
pound and quickly frozen in dry ice. Tissue sections were cut on a
cryostat (12 mm), fixed in cold acetone (10 minutes), and incubated
for 1 hour in blocking solution (PBS 10% donkey serum, 0.3%
triton-X). After blocking, sections were first incubated overnight at
4uC with rabbit anti-myosin Va primary antibody (1:500, Sigma).
For detection of primary antibodies from the same host species,
tissue sections were incubated with excess Fab fragment goat anti-
rabbit IgG (10 mM/ml; 1 hour RT) to present the first antibody as
a different species. A fluorescent-conjugated donkey anti-goat
secondary antibody (Alexa Fluor 488, Invitrogen) was used to
detect the first primary antibody. After extensive washing, the
same sections were incubated overnight with anti-rabbit nNOS,
(1:100 Santa Cruz), followed by fluorescent-conjugated secondary
antibody (Alexa Fluor donkey anti-rabbit 568) for 1 hour at RT.
Control slides were prepared as described above with the omission
of primary antibodies. Sections were examined using a laser
scanning confocal microscope (Zeiss LSM 710). High resolution
images were acquired sequentially from separate channels using
Zen Imaging software.
Immunoprecipitation
The molecular interaction between Myosin Va and nNOS in
WT fundus and CCP was determined by co-immunoprecipitation
(IP) experiments. The mucosa was removed from the GF by
microdissection. Tissues were lysed in IP extraction buffer
(Dynabeads Co-immunoprecipitation kit, Invitrogen) supplement-
ed with 100 mM NaCl, 2 mM MgCl2, 1 mM DTT, and protease
inhibitors for 15 min at 4uC. After incubation, homogenates were
centrifuged at 30006g for 5 minutes and the supernatant
representing the total protein lysate was collected. Protein
concentrations were determined using the bicinchoninic acid
protein assay (BCA) by measuring the absorbance at 280 nm with
a biophotometer (Eppendorf). Anti-nNOS antibody, was cova-
lently immobilized onto the surface of M-270 epoxy magnetic
beads (DynabeadsH Antibody Coupling Kit, Invitrogen) by
incubating the antibody-bead complex for 24 hrs under agitation
at 37uC. Equal amounts of the antibody-coupled beads (1.5 mg
per reaction) were added to protein lysates from both WT fundus
(1.7 mg/ml) and CCP (3.4 mg/ml) and incubated under agitation
for 1 hour at 4uC. After incubation, the beads with immobilized
proteins were collected by placing the tubes in a magnetic field
(DynaMagTM-2, Invitrogen) and the remaining supernatants were
stored. Immunoprecipitated complexes were eluted from beads by
incubation in EB-buffer (Invitrogen) for 5 minutes at RT and
separated from the antibody-coupled beads by magnet. Total
lysates (15 mg), purified protein complexes and supernatants from
the fundus and CCP were resuspended in sample loading buffer,
boiled for 5 minutes, loaded onto a tris-acetate SDS polyacryl-
amide gel and separated by electrophoresis. Proteins were then
transferred to a 0.45 mm pore nitrocellulose membrane (Invitro-
gen). Non-specific binding was inhibited by incubating membranes
in Tris Buffered Saline (TBS) with 5% dry milk for 1 hour.
Membranes were incubated overnight at 4uC with primary
antibodies for myosin Va or nNOS. Unbound antibody was
removed by extensive washing with TBS containing 0.05%Tween
20. Membranes were incubated for 1 hour at RT with horseradish
peroxidase-conjugated secondary antibody (Santa Cruz). After
washing, the membrane was incubated with chemiluminescence
substrate (Western Lightning plus-ECL, Perkin Elmer), and
immunoreactive bands were visualized by exposure of membrane
to radiographic film (Kodak Biomax).
Preparation of Smooth Muscle Tissues
After euthanasia induced by CO2 asphyxiation, animals were
weighed and the stomach and the penis were excised and placed in
cold Kreb’s solution (NaCl 120 mM; KCl 5.9 mM; NaHCO3
25 mM; Na2H2PO4 1.2 mM; MgCl2 N 6H2O 1.2 mM; CaCl2
2.5 mM; dextrose 11.5 mM). The stomach was opened by a
longitudinal incision along the greater curvature, and the gastric
mucosa was removed from the fundic portion of the organ by
stereoscopic micro-dissection. Four longitudinal smooth muscle
strips from the fundus were obtained from each animal. The penis
was isolated from the mid-shaft to the base of the crura. After
removing the fascia and corpus spongiosum, the septum was cut
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longitudinally to separate the two corpora cavernosa. Cavernosal
smooth muscle was exposed by removing the tunica albuginea. At
the end of the experiment, the weight of each tissue from the GF
and CCP was recorded after blotting on filter paper.
Muscle Tension Studies
Fundus and CCP smooth muscle tissues were isolated from
DBA and WT mice. Each end of the tissue was tied with silk, and
transferred to an organ bath containing Kreb’s solution main-
tained at 37uC and continuously gassed with carbogen (95%O2+
5%CO2). One end of each strip was attached to a fixed hook, and
the other end to a force transducer measuring isometric tension
(Grass Technologies). Smooth muscle strips from both GF and
CCP were stretched under 0.5 grams of tension and equilibrated
for 1 hour. Force measurements were displayed on a strip chart
recorder (Gould) and digitally acquired by computer (WinDaq
Software). After equilibration, tissue strips from the fundus were
contracted by addition of carbachol (CCh, 10 mM) to the organ
bath and contractile responses in WT and DBA animals were
compared. Contractile responses of muscle strips from WT and
DBA mice to high extracellular potassium (KCl 120 mM) were
also compared. In the CCP, pre-contraction of smooth muscle was
achieved by addition of phenylephrine (PE, 100 mM). Guaneth-
idine (1 mM) was added to inhibit noradrenergic transmission [24].
Nerve-mediated relaxation was elicited in pre-contracted tissues
by electrical field stimulation (EFS, 40V, 2–64 Hz, 0.5 ms pulse
duration, 10 seconds) delivered by platinum electrodes connected
to a stimulator (Harvard Apparatus). In smooth muscle tissues
obtained from WT, the effect of EFS-induced relaxation in the GF
and CCP was investigated in the presence of NOS inhibitor L-
nitro-L-Arginine Methyl Ester (L-NAME, 10 mM). The direct
effect of nitric oxide on smooth muscle relaxation was examined in
both GF and CCP by exposing pre-contracted tissue to
submaximal concentrations of NO donor sodium nitroprusside
(SNP, 1 mM).
Data Analyses and Statistics
The amplitude of contractile and relaxation responses were
reported as the difference in tension (expressed in Newton) before
and after the stimulus and normalized by the weight of the tissue
strip (expressed in grams). EFS induced relaxation responses from
the fundus were also expressed as a percent change from the active
tension achieved by CCh pre-contraction. Data are reported as
mean 6 SEM. Differences in means for the contractile or
relaxation responses to agonists and EFS before and after L-
NAME were analyzed by paired student’s t test. Comparison of
contractile or relaxation responses between WT and DBA were
analyzed by unpaired t-test followed by Holm-Sidak post-hoc
analysis. P,0.05 was considered significant.
Results
Expression and Distribution of Myosin Va in Fundus and
CCP and its Interaction with nNOS
Myosin Va immunoreactivity was detected in both gastric and
penile tissues. Myosin Va staining was specifically localized within
nNOS immunoreactive nerve varicosities coursing through
smooth muscle bundles in both tissues (figure 1). Coarse nerve
trunks in the CCP were also positive for myosin Va. Molecular
interaction between nNOS and myosin Va, determined by co-
immunoprecipitation, was demonstrated in both GF and CCP
(figure 1, right panels).
Nerve- mediated Relaxation in Gastric Fundus (GF)
Smooth muscle strips from the fundus of both WT and DBA
contracted after the addition of either KCl or CCh. The
contractile responses induced by KCl were similar (2.2560.2N/
g and 1.7861.6N/g respectively in WT and DBA mice, p = 0.07).
However, the contractile response to CCh was significantly lower
in DBA (2.1460.18 N/g) compared to WT fundus (3.7360.3 N/
g, p = 0.002). This reduced carbachol response was not further
investigated; however, it is possible that it may be due to impaired
membrane localization of cholinergic receptors in the smooth
muscle since myosin Va has been shown to regulate membrane
localization of cholinergic (nicotinic) receptors in striated muscle
[25].
In WT animals, carbachol pre-contracted tissue relaxed in
response to EFS in a frequency dependent manner, reaching
maximal relaxation at frequencies between 20 and 30 Hz.
Administration of L-NAME (10 mM), a non-selective NOS
inhibitor, had no effect on the amplitude of CCh-induced pre-
contraction (maximum amplitude 3.20660.36N/g) but signifi-
cantly reduced the relaxation induced by EFS. As shown in
figure 2, L-NAME significantly suppressed nerve-mediated
relaxation at all frequencies of stimulation above 2 Hz, suggesting
that the major component of nerve-mediated GF relaxation was
due to NO derived from NOS.
In the DBA mice, EFS also produced frequency dependent
relaxation; however, this relaxation response was significantly
lower than that in WT at all frequencies of stimulation (figure 3).
Since the pre-contraction amplitude was significantly different
between DBA and WT, the relaxation responses were normalized
by the CCh pre-contraction in each tissue. EFS-induced relaxa-
tions were still significantly lower in DBA than in WT mice at all
frequencies examined. At 20 Hz, the relaxation response in DBA
mice was 16.161.8% of the pre-contraction which was signifi-
cantly lower than the relaxation response (41.062.8%) in WT
animals (p = 0.01, n = 12 in each group).
The relaxation response induced by EFS in the presence of L-
NAME treatment in WT mice was compared with the nerve-
mediated relaxation in DBA mice. The suppression of nerve
mediated relaxation by L-NAME in WT mice at 20 Hz was not
significantly different from the decreased relaxation response in
DBA relative to WT (68.964.8% vs 67.366.5%). These
observations suggest that nerve mediated nitrergic relaxation in
GF was largely abolished in myosin Va deficient DBA mice.
The relaxation responses in the fundus elicited by the addition
of the NO donor SNP in CCh pre-contracted strips were not
different between tissues of WT and DBA mice (figure 4),
suggesting that myosin Va deficiency does not impair direct
smooth muscle relaxation induced by NO.
Nerve- mediated Relaxation in Corpora Cavernosa of
Penis (CCP)
In penile cavernosal smooth muscle tissue, phenylephrine (PE)
caused a stable, tonic contraction. The amplitude of contractile
responses induced by PE was not significantly different between
strains (0.4560.09 N/g and 0.3260.02 N/g respectively in WT
and DBA).
Pre-contracted CCP muscle strips from WT mice relaxed in
response to EFS in a frequency dependent manner. Administra-
tion of L-NAME did not affect the amplitude of PE-induced pre-
contraction in WT (0.3360.05 N/g) but significantly reduced
nerve-mediated relaxations at all the frequencies tested (Figure 5).
The maximal suppression of relaxation by L-NAME at 16 Hz was
73.365.9% of the untreated response, consistent with CCP
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relaxation being predominantly mediated by NO derived from
isoforms of NOS.
EFS-induced relaxation responses in DBA CCP tissue were
significantly lower than those in WT CCP tissue at all frequencies
(Figure 6). These observations suggest that nitrergic relaxation of
the CCP is also dependent on myosin Va. Nerve stimulated CCP
relaxation in DBA mice relative to WT was significantly greater
(53.166.9%) than the L-NAME-resistant WT relaxation relative
to the untreated response (25.264.4%, p,0.018, 16 Hz), indicat-
ing a residual NOS mediated relaxation component in DBA mice.
Cavernosal tissue from both WT and DBA mice, pre-contracted
with PE, relaxed to the same degree in response to the NO donor
SNP (1 mM) (Figure 7), suggesting that postjunctional smooth
muscle responses to nitrergic relaxants were not modified by
myosin Va deficiency in DBA mice.
Comparison of Relaxation Responses in GF and CCP
To determine whether myosin Va differentially affected
nitrergic relaxation in GF relative to CCP, we compared the
NO-mediated relaxation response with the myosin Va-dependent
relaxation response. The L-NAME sensitive relaxation response in
WT mice relative to the untreated response was similar in GF
compared to CCP (68.8613% vs 74.864.4%, respectively;
p = 0.44). The myosin Va dependent relaxation response, deter-
mined from the difference in relaxation between DBA and WT as
a percent of the WT response, was significantly lower in CCP
(38.965.8%) compared to GF (79.165.3%, p,0.001). Since the
Figure 1. Localization and interaction of myosin Va and nNOS in the fundus and corpora cavernosa (CCP). In both fundus (top panels)
and CCP (bottom panels), immunoreactivity for myosin Va (green) is present in nerve fibers that are immunoreactive for nNOS (red). Co-localization
(yellow) is present in projected image. Western blot on right shows positive bands for myosin Va and nNOS in total protein lysate (TP) in lane 1. In
lane 2, samples were immunoprecipitated for nNOS and blotted for myosin Va to demonstrate molecular interaction between these proteins in
fundus (top panel) and CCP (bottom panel).
doi:10.1371/journal.pone.0086778.g001
Figure 2. Effect of L-NAME on nerve-mediated relaxation in mouse gastric fundus. (A) Representative tracings before (untreated) and after
L-NAME treatment showing pre-contraction induced by carbachol (arrows) followed by relaxation due to increasing frequencies of stimulation in a
WT mouse. Note the relaxation response during the stimulation is followed by an off-contraction. (B) Relaxation response to EFS after L-NAME
treatment (gray triangles) was significantly lower than baseline relaxation response (black circles). [n = 5; * = significantly lower than baseline
response; p,0.0002 by paired t test].
doi:10.1371/journal.pone.0086778.g002
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total NO mediated relaxation response in CCP was not different
than in GF, this finding suggests that nitrergic relaxation may be
more sensitive to loss of myosin Va in GF than in CCP.
Discussion
The present study demonstrates an important role for myosin
Va in nitrergic neurotransmission. We showed, using disparate
smooth muscle neuromuscular junctions, that: 1) myosin Va
localizes in nitrergic nerve fibers in GF and CCP; 2) nNOS
interacts with myosin Va in both GF and CCP; 3) smooth muscle
relaxation in response to nitrergic nerve stimulation is suppressed
in DBA mice in both the GF and CCP due to impaired synthesis of
NO rather than defective post-junctional NO signaling.
The loss of smooth muscle relaxation in response to neuronal
stimulation in DBA mice is consistent with our previous
electrophysiological studies showing loss of inhibitory junction
potentials in these animals, despite normal hyperpolarization
responses to exogenous NO donors [20]. In isolated enteric nerve
varicosities from DBA animals, nNOSa expression was normal,
but membrane associated nNOSa was decreased, and NO
synthesis was impaired, showing that myosin Va deficiency may
cause loss of catalytic nNOSa activity by preventing its membrane
localization and thereby interfering with nitrergic neurotransmis-
sion [20]. The present mechanical study provides evidence for the
functional importance of myosin Va in inhibitory neurotransmis-
sion and relaxation of GF smooth muscles. L-NAME, a
nonselective NOS inhibitor suppressed neurally mediated relax-
ation by about 70%, indicating that the predominant component
of nerve-mediated relaxation in GF was nitrergic in nature. The
residual relaxation may be due to other inhibitory transmitters
including ATP and VIP [26–27]. The magnitude of the relaxation
response in DBA fundus was comparable to the L-NAME-resistant
relaxation response in WT muscle strips, suggesting that myosin
Va may be responsible for regulating nitrergic relaxation in GF.
Further studies are needed to fully define the non-nitrergic and
myosin Va insensitive inhibitory neurotransmitters in the stomach.
In the penis, neurogenic NO is fundamental to relaxation of
cavernosal smooth muscle and initiation of erection [4,6].
Accordingly, the present study showed that a dominant compo-
nent of EFS induced CCP relaxation was mediated by NO
released from penile nerves. Moreover, we showed that nitrergic
relaxation of CCP was impaired in myosin Va deficient DBA
mice, suggesting that nitrergic neurotransmission is regulated by
myosin Va in the penis. Analogous to nNOSa trafficking in enteric
nerve terminals, here we report the novel finding that transport of
PnNOS to the varicosity membrane in penile nerves may be
mediated by myosin Va. PnNOS differs from nNOSa by a 34
amino acid insert and is identical to nNOSm expressed in skeletal
and cardiac muscles [24,28]. Nevertheless, several lines of
Figure 3. Effect of myosin Va deficiency on nerve mediated relaxation in mouse gastric fundus. (A) Representative tracing showing
frequency dependent relaxation in a WT animal. (B) Representative tracing showing reduced relaxations in response to EFS in a DBA mouse. (C)
Quantification of frequency-relaxation responses in WT and DBA mice. Note that in DBA mice, relaxation responses are markedly decreased. [n = 12 in
each group; * = significantly lower than WT, unpaired t-test].
doi:10.1371/journal.pone.0086778.g003
Figure 4. Effect of NO donor on contractile response. After pre-contraction with carbachol (arrows), relaxation was induced by SNP (1 mM) in
WT (A) and DBA (B) fundus. (C) Graph shows that SNP induced relaxation was similar in magnitude in WT (black bars) and DBA (gray bars) mice. [n = 8
in each group, p = 0.433, unpaired t-test].
doi:10.1371/journal.pone.0086778.g004
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evidence support the possibility of PnNOS cycling to the varicosity
membrane in penile nerves. For example, PnNOS contains an N-
terminal PDZ domain that can interact with the scaffold protein
PSD95 (postsynaptic density 95 kDa) to facilitate its membrane
localization [29]. In addition, the adapter protein LC8, which can
bind nNOSa to myosin Va in enteric varicosities [20], is highly
expressed in penile nerves and colocalizes with PnNOS [28]. We
have shown here that myosin Va is localized to nNOS-positive
nerve fibers in cavernosal tissue and interacts with nNOS. These
observations suggest that myosin Va in penile nerves may act to
transport PnNOS to the varicosity membrane for its catalytic
activation and hence promote nitrergic neurotransmission in the
penis.
The myosin Va dependent relaxation response induced by
nerve stimulation was a smaller fraction of the WT response in
CCP tissue compared to the relative responses in the GF. This
difference was not due to a disparity in the overall extent of
nitrergic relaxation in gastric and penile smooth muscle, as the
nerve-mediated relaxation in the two tissues was similarly and
effectively suppressed by a nonselective NOS inhibitor, L-NAME.
These observations suggest that a portion of nerve-mediated
nitrergic transmission in CCP may be independent of myosin Va.
The larger residual nitrergic relaxation in CCP likely results from
acetylcholine mediated eNOS activation [30]. In contrast to
nitrergic relaxation in the GF, eNOS is an important source of
NO in the CCP for cavernosal smooth muscle relaxation and
sustained erection [4.6]. However, eNOS targeting to membrane
caveolae [31] does not appear to require myosin Va. Resolution of
the relative contribution of nNOS splice variants and eNOS, and
role of myosin Va, require further studies.
The equivalent postjunctional responses of WT and DBA
stomach and penis to exogenous NO suggest that the impaired
nitrergic relaxation induced by EFS in DBA mice is due to
defective synthesis of NO in nerve terminals, rather than a defect
in NO signaling in smooth muscle. This deficit in NO synthesis
may be related to inadequate localization of nNOS in the
appropriate signaling compartment at the membrane that is
required for its activation. Thus, the present study suggests that
deficiency of the intracellular motor protein, myosin Va, may be
involved in the pathogenesis of gastroparesis and erectile
dysfunction.
In many disorders of gastrointestinal motility, impaired nitrergic
function with near normal or only slightly reduced nNOS has been
reported. For example, nNOS content was normal in 60 and 80%
of gastric biopsies in idiopathic and diabetic gastroparesis,
respectively [32]. Similarly, nNOS uncoupling has been shown
Figure 5. Effect of L-NAME on nerve-mediated relaxation in mouse corpora cavernosa of penis. (A) Representative tracing showing pre-
contraction induced by phenylephrine (PE, arrows) and relaxation to increasing frequencies of stimulation in a WT mouse before (baseline) and after
L-NAME treatment. Note the relaxation responses increased in amplitude with increasing stimulus frequencies. (C) In graph, frequency-relaxation
responses under baseline conditions (black circles) were significantly attenuated by L-NAME (gray triangles) in WT mice. [n = 5; *significantly lower
than baseline; p = 0.00002, paired t-test].
doi:10.1371/journal.pone.0086778.g005
Figure 6. Effect of myosin Va deficiency on nerve mediated relaxation in mouse corpora cavernosa of penis. (A) Representative tracing
showing frequency dependent relaxation of pre-contracted CCP (PE, arrow) in a WT animal. (B) Representative tracing showing relaxation responses
induced by EFS in CCP of a DBA mouse. (C) Comparison of frequency-relaxation responses in WT (black circles) and DBA (gray triangles) CCP. [n = 12
for WT and n= 14 for DBA; * significantly lower than WT, unpaired t-test].
doi:10.1371/journal.pone.0086778.g006
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to be responsible for dysfunctional nitrergic vasorelaxation of
penile arteries from insulin-resistant obese Zucker rats [10].
Recently, expression of myosin Va has been reported to be
reduced in neuronal tissues from the brain of animal models of
diabetes mellitus [33]. Thus it is interesting to speculate that
myosin Va defects may contribute to the pathogenesis of diabetic
gastroparesis and erectile dysfunction.
If the function of nNOSa and pnNOS is regulated by myosin
Va, the phenotype of DBA mice might be expected to resemble
nNOS2/2mutants and other animal models of functional nNOS
deficiency. DBA mice, an inbred strain of myosin Va deficiency,
have a near normal life span, though they have been reported to
be difficult breeders [34]. The in vivo phenotypes of the gut and
penis in DBA mice are not well characterized. DBA mice have
lower levels of physical activity and lower food intake than WT
litters [35], but can present wide variation in food and water intake
[36–37]. However, fecal output has not been properly quantified.
The pathological changes in DBA mice were somewhat similar to
those seen in nNOSa2/2 mice. Mechanical studies have shown
impaired nitrergic relaxation in nNOSa2/2 mice [38], similar to
that reported here for DBA mice. Although nNOS2/2 mutants
do not have breeding difficulty, few frank gastrointestinal
symptoms have been reported, except gastric dilation which is
dependent on the feeding behavior of the mutants [39].
Nevertheless, with careful testing, delayed gastric emptying,
pyloric muscle thickening and motor dysfunction in nNOS2/2
mutants were revealed. The presence of redundant pathways and
compensatory mechanisms of relaxation may minimize the
resultant pathology of nNOSa2/2 mice. Likewise, the phenotype
of DBA mice may be tempered by the hypomorphic character of
the myosin Va deficiency. Further studies are needed to precisely
define the functional phenotype of myosin Va deficiency.
In summary, our immunofluorescence and mechanical studies
showed that myosin Va plays an important role in nitrergic
neurotransmission in smooth muscle of the gastric fundus and
penile corpora cavernosa as evidenced by the functional impair-
ment of nitrergic relaxation demonstrated in an animal model of
myosin Va deficiency. These studies suggest that loss of myosin Va
contributes to functional abnormalities, including gastric motility
disorders and erectile dysfunction.
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